ReviewFrontiers in oncology2021

Aberrant Metabolism as Inductor of Epigenetic Changes in Breast Cancer: Therapeutic Opportunities.

Jossimar Coronel-Hernández et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.